(Q43906449)

27 November 2017

title

Optimisation and validation of an angiotensin-converting enzyme inhibition assay for the screening of bioactive peptides (English)

1 reference

27 November 2017

3

Willy Verstraete

1 reference

27 November 2017

Vanessa Vermeirssen

1

1 reference

27 November 2017

John Van Camp

series ordinal

2

1 reference

27 November 2017

publication date

1 March 2002

1 reference

27 November 2017

published in

Journal of Proteomics

1 reference

27 November 2017

volume

51

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

75-87

1 reference

Combinations in the treatment of hypertension: ACE inhibitors and calcium antagonists

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

A continuous spectrophotometric assay for angiotensin converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine beta-lactoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

Biochemical properties of regulatory peptides derived from milk proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

The role of enzyme and substrate concentration in the evaluation of serum angiotensin converting enzyme (ACE) inhibition by enalaprilat in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

Isolation of acein-2, a novel angiotensin-I-converting enzyme inhibitory peptide derived from a tryptic hydrolysate of human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

LKPNM: a prodrug-type ACE-inhibitory peptide derived from fish protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

Substrate specificity and kinetic characteristics of angiotensin converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

The Catalytic Mechanism of Angiotensin Converting Enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

Inhibition of angiotensin converting enzyme: mechanism and substrate dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

A new method for the in vitro screening of inhibitors of angiotensin-converting enzyme (ACE), using the chromophore- and fluorophore-labelled substrate, dansyltriglycine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

Inhibitory effect of N-alpha-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline (MK-0521) on angiotensin converting enzyme in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

Endopeptidase 3.4.24.11 converts N-1-(R,S)carboxy-3-phenylpropyl-Ala-Ala-Phe-p-carboxyanilide into a potent inhibitor of angiotensin-converting enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

Selectivity of converting-enzyme inhibitors for angiotensin I versus bradykinin hydrolysis reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

BW A575C, a chemically novel agent with angiotensin converting enzyme inhibitor and beta-adrenoceptor-blocking properties

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

Serum angiotensin converting enzyme activity and response to angiotensin I in horses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-022X%2802%2900006-4

7 January 2021

10.1016/S0165-022X(02)00006-4

Identifiers

DOI

1 reference

27 November 2017

1 reference